PDUFA reauthorization offers a chance at clinical trial reforms. Will the US take it?

PDUFA reauthorization offers a chance at clinical trial reforms. Will the US take it? is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Kelly Bilodeau · 2026-09-14

The reauthorization could give Congress the opportunity to help streamline clinical trials and accelerate drug research.

Source: PharmaVoice